SEC Form 4 · accession 0001179110-16-020269
INTERMOLECULAR INC · IMI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Irwin Federman
Director
Period of report
Feb 24, 2016
Accepted (ET)
Feb 26, 2016 · 4:16 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001311241
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 per shareF1 | Feb 24, 2016 | P | 5,900 | $2.1189 | A | 255,897 | D | |
| Common Stock, $0.001 per shareF2 | holding | — | — | — | 4,280,779 | I | Directly owned by USVP IX |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The transaction was executed in multiple trades in prices ranging from $2.11 to $2.12, inclusive. The price reported in column 4 above reflects the weighted average price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
- F2Presidio Management Group IX, LLC ("PMG IX") is the general partner of US Venture Partners IX, L.P. ("USVP IX") and Irwin Federman, Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, Casey M. Tansey, and Philip M. Young, the managing members of PMG IX, may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein.